(1 - 8 von 10
)
Amgen and Dompe Biotec to Combine Commercial Investors
investors.amgen.com
... and chief executive officer of Dompe Biotec, while Marco Renoldi, currently managing director of Amgen Italy, will serve as its managing director. › amg...
Amgen, Dompe Biotec to combine operations in Italy
test.pharmabiz.com
The president of Amgen-Dompe will be Eugenio Aringhieri, who is currently president and chief executive officer of Dompe Biotec, while Marco Renoldi, ... › news
ITM – Press Releases Detail - ITM Radiopharma
itm-radiopharma.com
— Marco Renoldi, Chief Operating Officer at Nordic Nanovector, said: “We are pleased to extend our collaboration with a long-standing and ... › news
Nordic Nanovector ASA - allocation of PSUs - Finanzen.ch
www.finanzen.ch
— Marco Renoldi, COO was granted 45,000 PSUs. Marco Renoldi now holds 115,000 PSUs, 464,137 options and 92,888 shares. › amp › n...
Nordic Nanovector appoints Dr Reza Safaei as head of ...
www.manufacturingchemist.com
— Marco Renoldi, COO of Nordic Nanovector, said: “We are delighted to welcome Dr Safaei, who brings an extensive experience and relevant track ... › ...
Nordic Nanovector signs global clinical and commercial ...
www.biospectrumindia.com
— Marco Renoldi, Chief Operating Officer at Nordic Nanovector, said: "We are pleased to extend our collaboration with a long-time and reliable ... › ...
Nordic Nanovector, Isotope Technologies Enter Supply Pact
www.contractpharma.com
— Marco Renoldi, chief operating officer at Nordic Nanovector, said, "We are pleased to extend our collaboration with a long-time and reliable ... › ...
Shionogi launches London headquarter - BioSpectrum Asia
www.biospectrumasia.com
— ... and has recently made several key appointments: Dr Marco Renoldi, Dr Suhail Nurbhai, Dr Mark Sampson, Nina Strenitz and Joe Gaugas. › ...
sortiert nach Relevanz / Datum